- Report
- May 2025
- 193 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 191 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 182 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 185 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 181 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 198 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 193 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 181 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 185 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 142 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- January 2025
- 135 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 141 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 146 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 149 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 139 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- May 2025
- 138 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- May 2025
- 149 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- April 2025
- 146 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- February 2025
- 144 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- September 2024
- 147 Pages
Global
From €2686EUR$2,999USD£2,290GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more